The product catalog has been published: AC power supply 61700 series.

A cost-effective AC power supply dedicated to three-phase systems.

The 61700 series is a three-phase output dedicated AC stabilized power supply capable of providing three-phase four-wire + GND power supply. It can be connected to an external signal generator, and the LCD panel can display various measurement parameters. Additionally, dedicated software for avionics is available, allowing for testing according to MIL-STD-704F, RTCADO-160D, and ABD100 standards. A total of five models are available in the lineup. It is suitable not only for R&D and QC but also for automatic testing systems on production lines.

• Power Supplies

TOYOROBO Co., Ltd. has signed a general agency agreement with OUNITECH ROBOTICS, a robotics company engaged in the development and manufacturing of AI-powered cleaning robots, effective July 4, 2025. Prior to the domestic launch of 'RoboSweep' in Japan, we have initiated a proof of concept (PoC) at our office location in the complex facility "the SOHO," aimed at verifying and optimizing product performance suitable for the Japanese market. 'RoboSweep' is a robot developed to achieve safe and efficient cleaning operations in various environments such as commercial facilities, office buildings, healthcare and welfare, and sports complexes, equipped with advanced autonomous driving technology and AI algorithms. In this proof of concept (PoC), we will measure and evaluate the effectiveness of obstacle avoidance capabilities, cleaning quality, and operational efficiency within actual facilities, aiming for further optimization of product performance, including the Japanese facility environment and detailed operational capabilities.

The size of the Japanese soup market reached 700 million USD in 2024. Going forward, the IMARC Group predicts that the market will reach 900 million USD by 2033, showing a growth rate (CAGR) of 2.9% between 2025 and 2033. The Japanese soup market is experiencing stable growth, supported by consumer needs for convenience, instant preparation, and health consciousness. Innovations in taste, packaging, and functional ingredients continue to attract a diverse customer base. This report analyzes key trends in each market segment and provides country-level forecasts from 2025 to 2033. The report is categorized by type, category, packaging, distribution channel, region, and MIMO composition. This report focuses on market structure, positioning of key players, strategies, competitive dashboards, and corporate evaluation quadrants, providing a detailed analysis of the competitive landscape. And email: sales@imarcgroup.com

The Japanese LED display market reached 473.13 million USD in 2024. The IMARC Group forecasts that this market will grow at a compound annual growth rate (CAGR) of 11.88% between 2025 and 2033, reaching 1.29942 billion USD by 2033. The Japanese LED display market is steadily growing, supported by increased adoption in advertising, sports, transportation, and entertainment sectors. Advances in technology have improved display quality, energy efficiency, and versatility for a wide range of applications. This report analyzes key trends in each market segment and provides country-level forecasts from 2025 to 2033. The report is segmented based on technology insights, color insights, application insights, end-user insights, regional insights, and MIMO configuration insights. This report focuses on market structure, positioning of key players, strategies, competitive dashboards, and corporate evaluation quadrants, providing a detailed analysis of the competitive landscape. And email: sales@imarcgroup.com

The Japanese biosimilar market reached 475.8 million USD in 2024. Going forward, the IMARC Group predicts that the market size will reach 3.4196 billion USD by 2033, growing at an average annual growth rate of 22.7% from 2025 to 2033. The expansion of the Japanese biosimilar market is driven by the increasing demand for cost-effective biological products and the development of a regulatory framework to support it. The rising adoption of biosimilars in the treatment of oncology, autoimmune diseases, and chronic conditions is propelling market growth. This report analyzes key trends in each market segment and provides country-level forecasts from 2025 to 2033. The report is segmented based on insights into molecules, indications, and manufacturing types. It focuses on market structure, positioning of key players, strategies, competitive dashboards, and corporate evaluation quadrants, providing a detailed analysis of the competitive landscape. Email: sales@imarcgroup.com

Thank you very much for your continued support. We would like to inform you that our company will be closed for summer vacation on the following dates. ■ Summer Vacation Period From Wednesday, August 13, 2025, to Sunday, August 17, 2025. We will resume normal business hours on Monday, August 18, at 8:30 AM. We apologize for any inconvenience this may cause and appreciate your understanding.